Screener
Haemonetics HAE Ratios & Valuation
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 59%+2.1pp | 59%+4.0pp | 59.4%+6.1pp | 58.3%+5.6pp | 56.9%+4.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.5×-0.1× | 0.5×-0.1× | 0.5×-0.1× | |
| Liquidity | ||||||
| Current ratio | 3.1×+1.4× | 3×+1.3× | 1.7×-2.2× | 1.6×-1.8× | 1.7×-2.0× | |
| Leverage | ||||||
| Debt-to-equity | 1.4×0.0× | 1.6×0.0× | 1.3×0.0× | 1.4×0.0× | 1.4×0.0× | |
| Per Share | ||||||
| Book value per share | $18.32+0.4% | $16.82+3.9% | $19.40+8.3% | $17.82+3.9% | $18.25+3.9% | |
| Valuation | ||||||
| Market capitalization | $3.87B+6.3% | $2.62B-18.0% | $3.75B-4.3% | $2.35B-42.9% | $3.51B-16.7% | |
| Price / sales | 2.9×+0.2× | 2×-0.4× | 2.8×0.0× | 1.8×-1.3× | 2.6×-0.6× | |
| Price / book | 4.6×+0.5× | 3.3×-0.6× | 4.1×-0.2× | 2.8×-1.9× | 4×-0.7× |
FAQ
- What are Haemonetics's profit margins?
- Haemonetics (HAE) runs a 59.0% gross margin and a 19.0% operating margin, with a 13.3% net margin.
- Where do Haemonetics's ratios come from?
- Every ratio is computed from Haemonetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
